Stock Price Quote

SAAMYA BIOTECH (INDIA) LTD.

NSE : NABSE : 532905ISIN CODE : INE320H01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE1.970 (0 %)
PREV CLOSE ( ) 1.97
OPEN PRICE ( ) 1.97
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1005
TODAY'S LOW / HIGH ( )1.97 2.07
52 WK LOW / HIGH ( ) 1.972.07
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-08 2002
Management Info
- Chairman Y Manivardhan Reddy - Managing Director
Registered Office

Address Suite 104-106,Lumbini Enclave, Opp Nims ,Panjagutta,
Hyderabad,
Telangana-500082

Phone

Email info@saamyabiotech.com

Website www.saamyabiotech.com

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE

NEWS

23Feb Saamya Biotech (India) submits un-audi
Saamya Biotech (India) has informed about submission of Un-audited finan..
23Feb Saamya Biotech (India) informs about u
Saamya Biotech (India) has informed about submission of un-audited finan..
03Apr Saamya Biotech (India) informs about s
Saamya Biotech (India) has informed that the Extra Ordinary General Meet..
03Apr Saamya Biotech India informs about vot
Saamya Biotech India has informed about the details of voting results of..
06Mar Saamya Biotech India informs about boa
Saamya Biotech India has informed that a meeting of the Board of Directo..

Financials

in Millions
QTR Jun 19 ANNUAL 19
Net Profit-0.05-0.2
Gross Profit -0.05 -0.2
Operating Profit -0.05-0.2
Net Sales 0

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  14268.20 (14.14%)
M.Cap ( in Cr)18305.94
Abbott India (BSE)
peergroup  28793.10 (1.48%)
M.Cap ( in Cr)61183.33
Divi's Lab (BSE)
peergroup  6141.15 (3.38%)
M.Cap ( in Cr)163028.24
Mankind Pharma (BSE)
peergroup  2794.40 (4.34%)
M.Cap ( in Cr)111956.00
Lupin (BSE)
peergroup  2223.60 (3.18%)
M.Cap ( in Cr)101428.03

Shareholding Pattern

NON-INSTITUTION 74.38%
PROMOTERS 25.62%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Saamya Biotech (India) Ltd.

Saamya Biotech (India) Ltd. was incorporated in the year 2002. Its today's share price is 1.97. Its current market capitalisation stands at Rs 4.9 Cr. In the latest quarter, company has reported Gross Sales of Rs. 151.22 Cr and Total Income of Rs.145.14 Cr. The company's management includes Santosh Jagannath Sawant, P Suresh Reddy, P Naveen Chander Reddy, Y Sonia Reddy, Y Manivardhan Reddy.

It is listed on the BSE with a BSE Code of 532905 , NSE with an NSE Symbol of and ISIN of INE320H01019. It's Registered office is at Suite 104-106,Lumbini Enclave, Opp Nims ,PanjaguttaHyderabad-500082, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are P Murali & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.